• If you are wondering whether Axon Enterprise at around US$490 is starting to look expensive or still offers value, the stock’s recent swings give plenty to think about.
• The share price has moved sharply in the short term, with returns of 27.2% over the last week and 21.8% over the last 30 days. It is still down 13.0% year to date and 35.4% over the past year, while the 3 year and 5 year returns of 151.5% and 224.5% point to a very large longer term gain.
• Recent coverage around Axon Enterprise has focused on its role in public safety technology and how investors are reassessing companies linked to security and defense themes. This backdrop helps explain why sentiment around the stock can shift quickly as headlines change and investors reassess risk and opportunity.
• Despite that context, Axon Enterprise currently scores only 1 out of 6 on Simply Wall St’s valuation checks. The next step is to compare what different valuation methods say about the stock and then look at an even richer way to judge value that goes beyond the numbers alone.

Axon Enterprise scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Axon Enterprise Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and discounting them back to today using a required rate of return. It tries to answer a simple question for you: what are those future cash flows worth in today’s dollars?

For Axon Enterprise, the DCF used here is a 2 Stage Free Cash Flow to Equity model based on cash flow projections. The latest twelve month free cash flow is reported at about $28.7m, and analysts provide explicit forecasts out to 2028, where free cash flow is projected at $1,001.2m. Beyond that, Simply Wall St extrapolates additional years out to 2035, with each projected cash flow discounted back to today and summed.

On this basis, the model arrives at an estimated intrinsic value of about $387.70 per share, compared with a current share price close to $490. That gap implies the stock screens as around 26.4% more expensive than the DCF estimate. This approach therefore points to a valuation that is stretched rather than cheap.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 26.4%. Discover 46 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Axon Enterprise Price vs Sales

For companies that are already generating meaningful revenue, the P/S ratio is a useful way to compare what investors are paying for each dollar of sales, especially when earnings can be influenced by investment cycles or accounting items.

Higher growth expectations and lower perceived risk usually justify a higher P/S multiple, while slower growth or higher risk tend to support a lower, more conservative range. Context therefore matters when you look at where a stock’s multiple sits.

Axon Enterprise currently trades on a P/S of 13.24x. This is higher than the Aerospace & Defense industry average of 5.22x and also above the peer average of 7.72x, which suggests the market is assigning a premium to the stock compared with many competitors.

Simply Wall St’s proprietary Fair Ratio for Axon Enterprise is 15.58x. This is an estimate of what the P/S might be given factors such as the company’s revenue growth outlook, profit margins, industry, market cap and risk profile. Because it blends these company specific drivers, it can offer a more tailored reference point than a simple comparison with peers or the broad industry.

Compared with this Fair Ratio, Axon Enterprise’s current P/S of 13.24x is lower, which indicates the stock may be undervalued on this measure.

Result: UNDERVALUED

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Upgrade Your Decision Making: Choose your Axon Enterprise Narrative

Earlier the article mentioned that there is an even better way to understand valuation. This is where Narratives come in, giving you a simple story behind your numbers by linking your view of Axon Enterprise’s business, your forecast for revenue, earnings and margins, and your own fair value to the current share price. All of this is inside the Narratives tool on Simply Wall St’s Community page, where different investors can, for example, set a bullish Axon Narrative with a fair value around US$925.00 or a cautious one closer to about US$420.19. You can then watch those views refresh automatically as new news or earnings arrive so you can compare Fair Value to Price and decide whether the stock looks expensive or offers room based on the story you believe.

For Axon Enterprise however we will make it really easy for you with previews of two leading Axon Enterprise Narratives:

Think of these as two clear storylines you can compare against your own expectations before deciding whether the current share price around US$490.12 feels high, low, or about right.

Fair value in this bullish narrative: US$662.04 per share

Implied undervaluation vs last close: about 26.0% below this fair value

Revenue growth assumption: 28.14% a year

• Builds on the idea that Axon Enterprise’s AI public safety platform, premium SaaS bundles, and broader ecosystem can keep lifting average contract value and recurring revenue.
• Assumes continued global expansion and rising public safety needs support higher revenue, while margins improve as more agencies upgrade to premium and AI enabled plans.
• Accepts a high future P/E multiple, with analysts targeting US$662.04, and asks you to decide whether those growth, margin and valuation assumptions feel reasonable.

Fair value in this cautious narrative: US$420.19 per share

Implied overvaluation vs last close: about 16.6% above this fair value

Revenue growth assumption: 26.73% a year

• Focuses on risks from rapid tech commoditisation, tighter data privacy rules, and heavier reliance on government budgets that may pressure revenue visibility and margins.
• Highlights exposure to procurement cycles and sector multiple compression, where slower contract awards or lower valuation multiples could weigh on shareholder returns.
• Anchors on a lower fair value of US$420.19 that lines up with more bearish analyst targets, and challenges you to consider whether growth, margin and required P/E might end up closer to this path.

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.